A phase I, pharmacokinetic and pharmacodynamic dose escalation trial of weekly paclitaxel with interferon-alpha2b in patients with solid tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/16733646

Download in:

View as

General Info

PMID
16733646